<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00215280</url>
  </required_header>
  <id_info>
    <org_study_id>MV917090205</org_study_id>
    <nct_id>NCT00215280</nct_id>
  </id_info>
  <brief_title>Epidemiology and Control of Mansonella Perstans Infection in Uganda</brief_title>
  <official_title>Studies on the Epidemiology and Control of Mansonella Perstans Infection in Uganda</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DBL -Institute for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Uganda</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>DBL -Institute for Health Research and Development</source>
  <brief_summary>
    <textblock>
      Mansonella perstans (M. perstans) infection is widespread in Uganda. Knowledge about the
      epidemiology of this infection, and of the morbidity it induces is poor, and no effective
      treatment is available. The study aims at providing data on diagnostic, epidemiological,
      morbidity and treatment aspects of M. perstans infections in Uganda.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overall objective: to investigate diagnostic, epidemiological and treatment aspects of M.
      perstans in Uganda with relevance to control

      Specific objectives:

        1. To establish the pattern of diurnal periodicity of M. perstans microfilaraemia in humans

        2. To establish the patterns of M. perstans microfilaraemia and possible clinical
           manifestations related to this infection in two communities with medium to high
           endemicity

        3. To determine the efficacy of ivermectin alone and the combination of ivermectin and
           albendazole on M. perstans microfilaraemia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date>February 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>microfilariae periodicity patterns</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>epidemiology of M. perstans at community level</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>clinical spectre among infected</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>reduction in microfilaraemia</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>treatment effect on clinical manifestations</measure>
  </secondary_outcome>
  <enrollment>1000</enrollment>
  <condition>Mansonelliasis</condition>
  <condition>Pruritus</condition>
  <condition>Lymphoedema</condition>
  <condition>Abdominal Pains</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ivermectin and albendazole</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals &gt;= 5 years with or without M. perstans infection

        Exclusion Criteria:

          -  Individuals &lt; 5 years

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Asanta M Asio, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ministry of Health, Uganda</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Luwero</name>
      <address>
        <city>Luwero and Mukono</city>
        <state>Luwero and Mukono Districts</state>
        <country>Uganda</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Uganda</country>
  </location_countries>
  <link>
    <url>http://www.dblnet.dk</url>
  </link>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2005</study_first_submitted>
  <study_first_submitted_qc>September 21, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>April 19, 2007</last_update_submitted>
  <last_update_submitted_qc>April 19, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2007</last_update_posted>
  <keyword>Mansonella perstans</keyword>
  <keyword>microfilaraemia</keyword>
  <keyword>ivermectin</keyword>
  <keyword>albendazole</keyword>
  <keyword>Uganda</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphedema</mesh_term>
    <mesh_term>Abdominal Pain</mesh_term>
    <mesh_term>Pruritus</mesh_term>
    <mesh_term>Dipetalonema Infections</mesh_term>
    <mesh_term>Acanthocheilonemiasis</mesh_term>
    <mesh_term>Mansonelliasis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albendazole</mesh_term>
    <mesh_term>Ivermectin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

